6030 Participants Needed

Healthcare Models for Postpartum Hypertension

Recruiting at 2 trial locations
RP
Overseen ByRafael Pérez-Escamilla, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment Community Health Model (CHM), Remote Medical Model (RMM), Telehealth Model, Virtual Care Model, SoC, Standard of Care for Postpartum Hypertension?

The patient-centered medical home (PCMH) model, which shares similarities with the Community Health Model and other care models, has shown potential in improving care for patients with chronic conditions by providing coordinated, comprehensive, and accessible services. This approach may indirectly support the effectiveness of these models in managing postpartum hypertension by enhancing care delivery and patient outcomes.12345

Is the healthcare model for postpartum hypertension safe for humans?

The research articles reviewed do not provide specific safety data for the healthcare models mentioned, such as the Community Health Model or Telehealth Model, in the context of postpartum hypertension or other conditions.35678

How is the Community Health Model (CHM) and Remote Medical Model (RMM) treatment for postpartum hypertension unique?

The Community Health Model (CHM) and Remote Medical Model (RMM) for postpartum hypertension are unique because they emphasize patient-centered and team-based care, focusing on quality and safety, which is a shift from traditional hypertension treatments that may not prioritize these aspects. These models incorporate interprofessional collaboration and remote care, offering a more accessible and coordinated approach to managing high blood pressure after childbirth.29101112

What is the purpose of this trial?

The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.

Research Team

RP

Rafael Pérez-Escamilla, PhD

Principal Investigator

Yale University

Eligibility Criteria

This trial is for postpartum women who had a single live birth, speak English or Spanish, are on Medicaid or uninsured, and live in Connecticut, Massachusetts, or New York. They must be able to consent and not have severe medical conditions that interfere with participation. Women planning to move out of state soon or using illicit drugs cannot join.

Inclusion Criteria

You have recently given birth.
I am either uninsured or covered by Medicaid or its state equivalent.
You have given birth to one live baby (you may have had twins, but only one baby survived).
See 2 more

Exclusion Criteria

You have been diagnosed with a serious mental illness like schizophrenia or schizoaffective disorder.
My newborn is under someone else's care due to adoption or state involvement.
For participants without access to a phone, we will explore if there are options that will allow them to have access to a devise for the times when they need to communicate with the study team. If not, they will not be able to participate in the study since this study requires phone or telehealth communication with research staff and/or APPs, and CHWs depending on study phase.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

During postpartum hospital stay
1 visit (in-person)

Standard of Care

Participants receive standard postpartum care and are provided with an Omron blood pressure cuff

6 weeks
Weekly follow-up (telehealth)

Remote Medical Model (RMM)

Participants receive remote monitoring with additional follow-up visits as needed for high blood pressure or mental health concerns

6-12 weeks
At least 1 visit per week (telehealth)

Community Health Model (CHM)

Incorporates community health workers/doulas providing postpartum hypertension support and mental health engagement

6 weeks
Weekly visits (hybrid: in-person and virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including blood pressure checks and mental health assessments

6 months
Assessments at 6 weeks, 3 months, and 6 months postpartum

Treatment Details

Interventions

  • Community Health Model (CHM)
  • Remote Medical Model (RMM)
  • SoC
Trial Overview The study tests two healthcare delivery models aimed at early detection and management of postpartum hypertension against the standard care. One model uses remote monitoring (RMM), while the other involves community health approaches (CHM). The goal is to see which method improves clinical outcomes better.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Remote Medical Model (RMM)Experimental Treatment2 Interventions
Includes SoC plus RMM
Group II: Community Health Model (CHM)Experimental Treatment3 Interventions
Includes SoC, RMM plus CHM
Group III: Standard of Care (SoC)Active Control1 Intervention
Standard of Care for Postpartum Hypertension

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Findings from Research

The implementation of the patient-centered medical home (PCMH) model over a 9-year period led to increased engagement of diabetic patients with outreach, diabetes educators, and psychosocial services, indicating a shift in care processes.
Patients in the study showed a steady decrease in glycated hemoglobin levels, particularly among those with initially high levels, suggesting that the PCMH model can improve clinical outcomes for patients with diabetes.
Becoming a patient-centered medical home: a 9-year transition for a network of Federally Qualified Health Centers.Calman, NS., Hauser, D., Weiss, L., et al.[2022]
In a study of 9.3 million patients in the Veterans Health Administration, the implementation of the patient-centered medical home (PCMH) model led to a significant increase in primary care provider visits, especially among patients with high comorbidity, who saw 8 to 11 more visits per 1000 patients per quarter.
For patients aged 65 and older, PCMH implementation resulted in greater increases in PCP visits for both high- and low-comorbidity groups, while younger patients with high comorbidity also benefited, but low-comorbidity patients experienced a decrease in visits, highlighting the need for tailored approaches in healthcare planning.
Patient-Centered Medical Home Implementation in the Veterans Health Administration and Primary Care Use: Differences by Patient Comorbidity Burden.Wong, ES., Rosland, AM., Fihn, SD., et al.[2018]
In a study of 106 adults with uncontrolled diabetes, implementing a physician-pharmacist collaborative management (PPCM) model led to a significant reduction in hemoglobin A1c (HbA1c) levels, indicating improved glucose control.
The PPCM model did not significantly affect the rates of recommended vaccinations or cardiovascular risk reduction medications, suggesting its primary benefit lies in enhancing diabetes management rather than broader health interventions.
Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With Uncontrolled Diabetes.Peterson, J., Hinds, A., Garza, A., et al.[2022]

References

Becoming a patient-centered medical home: a 9-year transition for a network of Federally Qualified Health Centers. [2022]
Patient-Centered Medical Home Implementation in the Veterans Health Administration and Primary Care Use: Differences by Patient Comorbidity Burden. [2018]
Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With Uncontrolled Diabetes. [2022]
The patient-centered medical home, electronic health records, and quality of care. [2014]
Back to Basics: The Perioperative Surgical Home. [2015]
Integration of collaborative medication therapy management in a safety net patient-centered medical home. [2022]
Applying network analysis to assess the development and sustainability of multi-sector coalitions. [2022]
Understanding the patient-centered medical home. [2014]
Interprofessional Collaboration With Pharmacist-Driven Education for Hypertension Control in Federally Qualified Health Center Patients. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Measuring Local Public Health and Primary Care Collaboration: A Practice-Based Research Approach. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Quality and equity of primary care with patient-centered medical homes: results from a national survey. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Stakeholder Perspectives on Changes in Hypertension Care Under the Patient-Centered Medical Home. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security